Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements.
Hashimoto J, Chonan K, Aoki Y, Ugajin T, Yamaguchi J, Nishimura T, Kikuya M, Michimata M, Matsubara M, Araki T, Hozawa A, Ohkubo T, Imai Y. Hashimoto J, et al. Among authors: nishimura t. J Hypertens. 2003 Apr;21(4):805-11. doi: 10.1097/00004872-200304000-00025. J Hypertens. 2003. PMID: 12658028 Clinical Trial.
Progress report on the HOMED-BP Study: hypertension objective treatment based on measurement by electrical devices of blood pressure study.
Aoki Y, Asayama K, Ohkubo T, Nishimura T, Kikuya M, Metoki H, Hozawa A, Hashimoto J, Michimata M, Matsubara M, Araki T, Imai Y; HOMED-BP Study Group. Aoki Y, et al. Among authors: nishimura t. Clin Exp Hypertens. 2004 Feb;26(2):119-27. doi: 10.1081/ceh-120028548. Clin Exp Hypertens. 2004. PMID: 15038622 Free article. Clinical Trial.
Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Nishimura T, Hashimoto J, Ohkubo T, Kikuya M, Metoki H, Asayama K, Totsune K, Imai Y. Nishimura T, et al. Clin Exp Hypertens. 2005 Aug;27(6):477-89. doi: 10.1081/CEH-200067668. Clin Exp Hypertens. 2005. PMID: 16081340 Free article.
Real-world clinical practice of current periprocedural anticoagulation management in catheter ablation of atrial fibrillation: Data from a large prospective ablation registry.
Taomoto Y, Miyazaki S, Nagata Y, Nitta J, Inaba O, Shirai Y, Tanaka Y, Sekiguchi Y, Inamura Y, Sagawa Y, Mizukami A, Azegami K, Iwai S, Hachiya H, Ono Y, Takahashi A, Sasaki T, Yamauchi Y, Okada H, Suzuki A, Suzuki M, Handa K, Hirao K, Nakajima J, Nishimura T, Tao S, Takigawa M, Sasano T. Taomoto Y, et al. Among authors: nishimura t. J Arrhythm. 2025 Jan 14;41(1):e13182. doi: 10.1002/joa3.13182. eCollection 2025 Feb. J Arrhythm. 2025. PMID: 39817001 Free PMC article.
Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models.
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Matono T, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T; Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hatanaka T, et al. Among authors: nishimura t. J Gastroenterol Hepatol. 2025 Jan 6. doi: 10.1111/jgh.16871. Online ahead of print. J Gastroenterol Hepatol. 2025. PMID: 39762722
5,254 results